通过向补充受体C5aR1来改善免疫抑制微环境中的放射治疗.
Callum Beach1, David MacLean1, Dominika Majorova1
1Department of Oncology, University of Oxford, Oxford, United Kingdom.
The Journal of clinical investigation
|October 12, 2023
概括
向补充受体C5aR1 (CD88) 提高了放射治疗的疗效,即使在免疫抑制性结直肠癌中也是如此. 这种方法增强了瘤细胞亡和T细胞透,为难以治疗的瘤提供了新的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 大肠直肠癌通常具有免疫抑制的微环境,阻碍T细胞透,降低患者的生存率.
- 在这种瘤中改善治疗反应仍然是一个重大的临床挑战.
研究的目的:
- 为了确定可用药物的标,可以克服瘤免疫抑制并提高放射治疗的疗效.
- 研究补充受体C5aR1 (CD88) 在结直肠癌中的作用及其作为治疗点的潜力.
主要方法:
- 综合查方法,以确定癌症特定的脆弱性.
- 抑制C5aR1并评估其对瘤放射治疗反应的影响.
- 对瘤细胞和免疫细胞上的C5aR1表达的分析.
- 对诱导亡和NF-κB通路激活的评估.
主要成果:
- 鉴定出C5aR1是一种可用药物的点,可以改善放射治疗,即使在瘤中T细胞透率较低.
- C5aR1在恶性上皮细胞上表达,这表明瘤特异性功能超出其免疫作用.
- 抑制C5aR1导致NF-κB依赖性亡增加,特别是在瘤细胞中,而不是正常组织中.
- 在免疫抑制性结直肠癌模型中准C5aR1增强放射治疗.
结论:
- 补充基因表达增加作为辐射瘤的应激反应.
- 向C5aR1代表了改善放射治疗结果的有希望的策略,特别是在免疫抑制性结直肠癌中.
- C5aR1在调节恶性细胞命运和克服治疗耐药性方面发挥着关键作用.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.4K
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.8K
相关概念视频
Tumor Immunotherapy
539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
